Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Derma Numb] — RxCUI 1747492
RxNorm drug concept · Semantic branded drug
RxCUI 1747492
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1747492
Official nameLidocaine hydrochloride 0.04 MG/MG Topical Gel [Derma Numb]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDerma Numb 4 % Topical Gel; Derma Numb 0.04 MG/MG Topical Gel
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Prescription patches treat nerve pain that lingers after shingles, called post-herpetic neuralgia. Over-the-counter patches give temporary relief of minor pain, and some list joint...
- It depends on the product. Ztlido is worn for up to 12 hours in a 24-hour period. The over-the-counter Coralite 4% patch comes off after at most 8 hours. Always follow your label.
- How long can I leave a lidocaine patch on?
- No. Heat on the patch increases how much lidocaine gets into your blood. With Ztlido, you can apply the patch after brief moderate heat, but do not put a heating pad or electric bl...
🕸️ Concept Web — How Lidocaine hydrochloride 0.04 MG/MG Topical Gel [... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Lidocaine hydrochloride 0.04 MG/MG Topical Gel [Derma Numb]
RxCUI 1747492 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Lidocaine
6387IN -
Lidocaine hydrochloride
142440PIN
-
Lidocaine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Derma Numb
1312261BN
-
Derma Numb
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Lidocaine Topical Gel
377965SCDF -
Lidocaine hydrochloride Topical Gel
2648601SCDFP -
Lidocaine Topical Product
1164666SCDG -
Lidocaine hydrochloride Topical Product
2661923SCDGP -
Lidocaine Topical Gel [Derma Numb]
1747491SBDF -
Lidocaine hydrochloride Topical Gel [Derma Numb]
2658475SBDFP -
Derma Numb Topical Product
1312264SBDG -
Topical Gel
346286DF - +1 more in this family
-
Lidocaine Topical Gel
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Lidocaine hydrochloride 0.04 MG/MG Topical Gel
1010077SCD -
Lidocaine hydrochloride 0.04 MG/MG
1010076SCDC -
Lidocaine hydrochloride 0.04 MG/MG [Derma Numb]
1747490SBDC
-
Lidocaine hydrochloride 0.04 MG/MG Topical Gel
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Lidocaine hydrochloride 0.04 MG/MG Topical Gel
SCD · 1010077 -
Lidocaine hydrochloride 0.04 MG/MG
SCDC · 1010076 -
Lidocaine Topical Gel
SCDF · 377965 -
Lidocaine hydrochloride Topical Gel
SCDFP · 2648601 -
Lidocaine Topical Product
SCDG · 1164666 -
Lidocaine hydrochloride Topical Product
SCDGP · 2661923
Brand-Name Concepts
-
Lidocaine hydrochloride 0.04 MG/MG [Derma Numb]
SBDC · 1747490 -
Lidocaine Topical Gel [Derma Numb]
SBDF · 1747491 -
Lidocaine hydrochloride Topical Gel [Derma Numb]
SBDFP · 2658475 -
Derma Numb Topical Product
SBDG · 1312264 -
Derma Numb
BN · 1312261
📦 FDA Products & Package NDCs
2 products · 3 package NDCs
3 package NDCs map to RxCUI 1747492 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 70188-0005-01 | 28 g in 1 PACKAGE (70188-005-01) | Derma Numb Pain Relief | A.T.S. Laboratories, LLC | 2015-07-01 |
| 70188-0005-04 | 113 g in 1 PACKAGE (70188-005-04) | Derma Numb Pain Relief | A.T.S. Laboratories, LLC | 2015-07-01 |
| 70188-0006-01 | 57 g in 1 PACKAGE (70188-006-01) | DermaNumb Analgesic | A.T.S. Laboratories, LLC | 2015-07-01 |
Observed labelers:
A.T.S. Laboratories, LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.